Skip to main content
. 2022 Jul 18;10:911551. doi: 10.3389/fpubh.2022.911551

Table 2.

Risk factors affecting SVR in HCV-infected patients with PR treatment.

Variables Odds Ratio 95% CI P
Lower Upper
HCV RNA (log IU/mL) (≤ 6 = 0; >6 = 1) 1.24 1.01 9.36 0.0402
HCV Genotype (non GT1 = 0; GT1 = 1) 1.86 1.12 9.45 0.0276
Baseline IP-10 levels (pg/mL) (≤ 450 = 0; >450 = 1) 4.39 1.12 16.452 0.0235
IP-10 decline degree at 12w (>30% = 0; ≤ 30% = 1) 6.68 1.96 19.48 0.0145
Constant 1.489